Why is Gennex Lab. falling/rising?

As of 10-Nov, Gennex Laboratories Ltd is experiencing a price increase, currently at 15.11, reflecting a rise of 0.85 or 5.96%. The stock has shown a trend reversal, gaining after four consecutive days of decline. Despite a recent drop in investor participation, with delivery volume falling by 41.68% against the 5-day average, the stock has outperformed its sector by 4.91% today. Over the past month, Gennex has seen a significant increase of 23.95%, although it remains down 7.53% year-to-date and 27.53% over the past year. The stock's moving averages indicate it is performing better than the 20-day, 50-day, 100-day, and 200-day averages, but is lower than the 5-day moving average.
In the broader market context, Gennex's recent performance contrasts with the Sensex, which has only increased by 1.25% over the past month. This suggests that while Gennex is recovering from its recent downturn, it is still underperforming in the longer term, as evidenced by its year-to-date and one-year returns. The stock's ability to gain today despite a decrease in investor participation indicates a potential shift in market sentiment, which may be influenced by broader market trends or company-specific developments not detailed in the available data.